谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

MajesTEC-7: A Phase 3, Randomized Study of Teclistamab + Daratumumab + Lenalidomide (Tec-DR) Versus Daratumumab + Lenalidomide + Dexamethasone (DRd) in Patients with Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant

Amrita Y. Krishnan,Salomon Manier,Evangelos Terpos,Saad Usmani, Josephine Khan,Rachel Pearson,Suzette Girgis,Yue Guo, Dana McAleer,Yunsi Olyslager,Tobias Kampfenkel,Niels W.C.J. van de Donk

Blood（2022）

引用 5|浏览29
暂无评分
关键词
multiple myeloma,dexamethasone
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要